Everolimus

Red

Brand Name(s):Afinitor

Indication: Cancer -breast (hormone receptor-positive, HER2/neu negative advanced)

Rationale:1

Considered:Jul-12

Review Date:Jan-22

Comments:
NICE TA421
Everolimus with exemestane for treating advanced breast cancer after endocrine therapy
Dec-16
…………………………
NICE CG 81 – Advanced breat cancer (diagnosis & treatment)
Information can be found at: http://www.nice.org.uk/guidance/CG81
July 2014